A 12-weeks Study to Evaluate Sulforaphane in Treatment of Autism Spectrum Disorder

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Autism Spectrum Disorder
Interventions
DIETARY_SUPPLEMENT

Sulforaphane

Sulforaphane (SFN) is a compound within the isothiocyanate group of organosulfur compounds. It is obtained from cruciferous vegetables such as broccoli, Brussels sprouts or cabbages.

OTHER

Placebo

Placebo tablet is composed of starch.

Trial Locations (2)

410001

The second Xiangya hospital of central south university, Changsha

510000

Guangzhou Huiai Hospital, Guangzhou

All Listed Sponsors
collaborator

Davis family funding

UNKNOWN

collaborator

University of California

OTHER

collaborator

University of Illinois at Chicago

OTHER

lead

Central South University

OTHER

NCT02879110 - A 12-weeks Study to Evaluate Sulforaphane in Treatment of Autism Spectrum Disorder | Biotech Hunter | Biotech Hunter